QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Eagerly-Anticipated Commercial Launch of Biopharmaceuticals Contract Services Business
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, this morning announced the commercial launch of its Biopharmaceuticals Contract Services Business. The eagerly-anticipated launch follows PBIO’s December 2017 acquisition of the assets of BaroFold, Inc., including patents, equipment, and other intellectual property relating to its unique, high pressure-based protein disaggregation and refolding platform. PBIO expects the technology platform to offer substantial improvement in the quality and costs of manufacturing protein therapeutics. “We are excited to announce the launch of our Biopharmaceutical Contract Services Business…